How to Get Zolgensma Covered by Cigna in Michigan: Complete Prior Authorization and Appeal Guide (2024)
Answer Box: Getting Zolgensma Covered by Cigna in Michigan Cigna covers Zolgensma (onasemnogene abeparvovec) for spinal muscular atrophy (SMA) in Michigan with prior authorization requiring genetic confirmation of bi-allelic SMN1 mutations, age under 2 years, anti-AAV9 titer ≤1:50, and recent labs (creatinine <1.0 mg/dL, hemoglobin 8-18